Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma

International Journal of Hematology

Volumn 84, Issue 4, 2006, Pages 354-358

  Isshiki, Ikuko ^a   Okamoto, Shinichiro ^a   Kakimoto, Tsunenori ^a   Chen, Chien Kang ^a   Mori, Takehiko ^a   Yokoyama, Kenji ^a   Hattori, Yutaka ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune disease; Autologous stem cell transplantation; Immune reconstitution; Multiple myeloma; Relapse

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BULLOUS PEMPHIGOID; CASE REPORT; CD34 SELECTION; FEMALE; HUMAN; LYMPHOCYTE DEPLETION; MULTIPLE MYELOMA; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; AUTOTRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENT DISEASE;

CD34 ANTIGEN; MELPHALAN; STEROID;

AGED; ANTIGENS, CD34; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; FEMALE; HUMANS; LYMPHOCYTE DEPLETION; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PEMPHIGOID, BULLOUS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; SJOGREN'S SYNDROME; STEROIDS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 34247205214     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06029     Document Type: Article

References (31)

1. Attal M, Harousseau JL, Stoppa AM, et al, for the Intergroupe Français du Myélome. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996;335:91-97.
2. Child JA, Morgan GJ, Davies FE, et al, for the Medical Research Council Adult Leukemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875-1883.
3. Palumbo A, Bringhen S, Petrucci MT, et al. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood. 2004;104:3052-3057.
4. Sullivan KM, Furst DE. The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. J Rheumatol Suppl. 1997;48:1-4.
5. Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1997;19:643-645.
6. McSweeney PA, Nash RA, Storb R, Furst DE, Gauthier J, Sullivan KM. Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. J Rheumatol Suppl. 1997;48:79-84.
7. Nash RA, McSweeney PA, Storb R, et al. Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. J Rheumatol Suppl. 1997;48:72-78.
8. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al, for the Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005;35:869-879.
9. Snowden JA, Patton WN, O'Donnell JL, Hannah EE, Hart DN. Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997;19:1247-1250.
10. Euler HH, Marmont AM, Bacigalupo A, et al. Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood. 1996;88:3621-3625.
11. Cooley HM, Snowden JA, Grigg AP, Wicks IP. Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum. 1997;40:1712-1715.
12. Lambertenghi-Deliliers GL, Annaloro C, Della Volpe A, Oriani A, Pozzoli E, Soligo D. Multiple autoimmune events after autologous bone marrow transplantation. Bone Marrow Transplant. 1997;19:745-747.
13. Rösler W, Manger B, Repp R, Kalden JR, Gramatzki M. Autologous PBPCT in a patient with lymphoma and Sjogren's syndrome: complete remission of lymphoma without control of the autoimmune disease. Bone Marrow Transplant. 1998;22:211-213.
14. Ishikawa F, Shigematsu H, Gondo H, Okamura T, Niho Y. Autoreactive antibodies following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1998;22:729-731.
15. Koch B, Kranzhofer N, Pfreundschu M, Pees HW, Trumper L. First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients. Bone Marrow Transplant. 2000;26:673-675.
16. Ferraccioli G, Damato R, De Vita S, Fanin R, Damiani D, Baccarani M. Haematopoietic stem cell transplantation (HSCT) in a patient with Sjogren's syndrome and lung MALT lymphoma cured lymphoma not the autoimmune disease. Ann Rheum Dis. 2001;60:174-176.
17. Imamura R, Inoue H, Kato K, et al. Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002;30:527-529.
18. Jillella AP, Kallab AM, Kutlar A. Autoimmune thrombocytopenia following autologous hematopoietic cell transplantation: review of literature and treatment options. Bone Marrow Transplant. 2000;26:925-927.
19. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica. 2000;85:832-838.
20. Breban M, Fernandez-Sueiro JL, Richardson JA, et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol. 1996;156:794-803.
21. Atkinson JP. Some thoughts on autoimmunity. Arthritis Rheum. 1995;38:301-305.
22. Traynor A, Burt RK. Haematopoietic stem cell transplantation for active systemic lupus erythematosus. Rheumatology (Oxford). 1999;38:767-772.
23. van Bekkum DW. Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation. Rheumatology (Oxford). 1999;38:757-761.
24. Vossen JM, Brinkman DM, Bakker B, Hoogerbrugge PM, ten Cate R. Rationale for high-dose cyclophosphamide and medium-dose total body irradiation in the conditioning of children with progressive systemic and polyarticular juvenile chronic arthritis before autologous stem cell transplantation. Rheumatology (Oxford). 1999;38:762-763.
25. McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood. 2002;100:1602-1610.
26. Thomas ED. Pros and cons of stem cell transplantation for autoimmune disease. J Rheumatol. 1997;24:100-102.
27. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood. 2003;102:2364-2372.
28. van Bekkum DW. BMT in experimental autoimmune diseases. Bone Marrow Transplant. 1993;11:183-187.
29. Pearson CM, Wood FD. Passive transfer of adjuvant arthritis by lymph node or spleen cells. J Exp Med. 1964;120:547-560.
30. Karussis DM, Slavin S, Ben-Nun A, et al. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol. 1992;39:201-210.
31. Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 2002;46:2301-2309.